Company
KisoJi
Breakthrough antibody discovery for breakthrough therapeutics
Also known as KisoJi Biotechnology, KisoJi Biotechnology Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- KisoJi Biotechnology Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
KisoJi is a leading next-generation antibody company discovering and developing highly differentiated antibody therapeutics to address difficult targets in oncology and other diseases.
Funding snapshot
- Total raised
- $41MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Undisclosed, $41M2024-12-02
Funding rounds
- Round, 2024
- $41M2024-12-02, Company stated
Loading relationship preview